Lung Cancer Drugs Market Research Reports

Global Lung Cancer Therapeutics Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global Lung Cancer Therapeutics Market Research and Forecast, 2018-2023

  • Report
From
Global Lung Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Lung Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023

  • Report
From
Global Non-Small Cell Lung cancer Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Non-Small Cell Lung cancer Market Research and Forecast 2018-2023

  • Report
From
World Non Small-Cell Lung Cancer Market - Opportunities and Forecasts, 2014 - 2022 - Product Thumbnail Image

World Non Small-Cell Lung Cancer Market - Opportunities and Forecasts, 2014 - 2022

  • Report
From
World Lung Cancer Therapeutics Market - Opportunities and Forecasts, 2014 - 2022 - Product Thumbnail Image

World Lung Cancer Therapeutics Market - Opportunities and Forecasts, 2014 - 2022

  • Report
From
World Paclitaxel Injection Market - Opportunities and Forecasts, 2014 - 2022 - Product Thumbnail Image

World Paclitaxel Injection Market - Opportunities and Forecasts, 2014 - 2022

  • Report
From
Global Lung Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Lung Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Global Non-Small Cell Lung Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Non-Small Cell Lung Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Drug Analysis: Tecentriq - Product Thumbnail Image

Drug Analysis: Tecentriq

  • Drug Pipelines
  • 82 Pages
From
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market - Product Thumbnail Image

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • Report
  • 161 Pages
From
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • 85 Pages
From
Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line - Product Thumbnail Image

Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line

  • Report
  • 113 Pages
From
CAS 95058-81-4 Gemcitabine Chemical World Report - Product Thumbnail Image

CAS 95058-81-4 Gemcitabine Chemical World Report

  • Report
  • 2134 Pages
CAS 949023-16-9 Paclitaxel side chain acid Chemical World Report - Product Thumbnail Image

CAS 949023-16-9 Paclitaxel side chain acid Chemical World Report

  • Report
  • 2027 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • 2111 Pages
CAS 63717-27-1 Amifostine hydrate Chemical World Report - Product Thumbnail Image

CAS 63717-27-1 Amifostine hydrate Chemical World Report

  • Report
  • 2066 Pages
CAS 71486-22-1 Vinorelbine Chemical World Report - Product Thumbnail Image

CAS 71486-22-1 Vinorelbine Chemical World Report

  • Report
  • 2151 Pages
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
CAS 865-21-4 Vinblastine Chemical World Report - Product Thumbnail Image

CAS 865-21-4 Vinblastine Chemical World Report

  • Report
  • 2016 Pages
CAS Cyclophosphamide World Consumption Report - Product Thumbnail Image

CAS Cyclophosphamide World Consumption Report

  • Report
  • 2091 Pages
Loading Indicator

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more

adroll